{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:48:48Z","timestamp":1790765328526,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.nmd.2023.12.014","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:47:36Z","timestamp":1703378856000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders"],"prefix":"10.1016","volume":"38","author":[{"given":"Lizan","family":"Stinissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sietse","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeno","family":"van Tienen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Reghan","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wija","family":"Oortwijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-7295","authenticated-orcid":false,"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.12.014_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2023.12.014_bib0002","article-title":"Designing clinical trials for rare diseases: unique challenges and opportunities","volume":"2","author":"Pizzamiglio","year":"2022","journal-title":"Nat Rev Methods Prim"},{"key":"10.1016\/j.nmd.2023.12.014_bib0003","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2023.12.014_bib0004","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.nmd.2021.08.003","article-title":"X-linked myotubular myopathy","volume":"31","author":"Lawlor","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.12.014_bib0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nmd.2023.12.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197513","article-title":"Mitochondrial disease patient motivations and barriers to participate in clinical trials","volume":"13","author":"Zolkipli-Cunningham","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2023.12.014_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1740774517751118","article-title":"Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders","volume":"15","author":"Peay","year":"2018","journal-title":"Clin Trials"},{"key":"10.1016\/j.nmd.2023.12.014_bib0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JND-200541","article-title":"Decision-making and selection bias in four observational studies on duchenne and becker muscular dystrophy","volume":"7","author":"Naarding","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.12.014_bib0009","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10897-017-0190-8","article-title":"An evidence-based, community-engaged approach to develop an interactive deliberation tool for pediatric neuromuscular trials","volume":"27","author":"Moultrie","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.nmd.2023.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40120-022-00360-w","article-title":"The Cure SMA clinical trial experience survey: a study of trial participant perspectives on clinical trial management and patient-centric management practices","volume":"11","author":"Peterson","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nmd.2023.12.014_bib0011","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.nmd.2023.10.011","article-title":"The impact of clinical trial participation on quality of life and psychosocial well-being in children with Duchenne muscular dystrophy and their parents","volume":"33","author":"Geuens","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.12.014_bib0012","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12916-019-1476-5","article-title":"The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence","volume":"18","author":"Naidoo","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.nmd.2023.12.014_bib0013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1188\/21.CJON.647-654","article-title":"Clinical trial participation: a pilot study of patient-identified barriers","volume":"25","author":"McKinney","year":"2021","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.nmd.2023.12.014_bib0014","first-page":"1435","article-title":"Factors that influence a patient's decision to participate in a phase I cancer clinical trial","volume":"27","author":"Schutta","year":"2000","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.nmd.2023.12.014_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10897-017-0143-2","article-title":"Enrolling genomics research participants through a clinical setting: the impact of existing clinical relationships on informed consent and expectations for return of research results","volume":"27","author":"Berrios","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.nmd.2023.12.014_bib0016","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ppul.25355","article-title":"New trach mom here\u2026\": a qualitative study of internet-based resources by caregivers of children with tracheostomy","volume":"56","author":"Meyer-Macaulay","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2023.12.014_bib0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13023-022-02317-6","article-title":"The involvement of rare disease patient organisations in therapeutic innovation across rare paediatric neurological conditions: a narrative review","volume":"17","author":"Nguyen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2023.12.014_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/RHU.0000000000001821","article-title":"Factors associated with participation in clinical trials among patients with lupus","volume":"28","author":"Harry","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.nmd.2023.12.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106740","article-title":"Inclusion and diversity in clinical trials: actionable steps to drive lasting change","volume":"116","author":"Kelsey","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.nmd.2023.12.014_bib0020","series-title":"INV05: engaging patients from diverse backgrounds in NMD research","author":"Ramdharry","year":"2023"},{"key":"10.1016\/j.nmd.2023.12.014_bib0021","series-title":"Poster 409: lessons learnt from trials in centronuclear myopathies: a qualitative study from the patient perspective","author":"Stinissen","year":"2023"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623008453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623008453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:32:27Z","timestamp":1729110747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623008453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":21,"alternative-id":["S0960896623008453"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.12.014","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The experience of clinical study and trial participation in rare diseases: A scoping review of centronuclear myopathy and other neuromuscular disorders","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}